Literature DB >> 29324789

An L213A variant of β-glycosidase from Sulfolobus solfataricus with increased α-L-arabinofuranosidase activity converts ginsenoside Rc to compound K.

Ji-Hyeon Choi1, Kyung-Chul Shin1, Deok-Kun Oh1.   

Abstract

Compound K (C-K) is a crucial pharmaceutical and cosmetic component because of disease prevention and skin anti-aging effects. For industrial application of this active compound, the protopanaxadiol (PPD)-type ginsenosides should be transformed to C-K. β-Glycosidase from Sulfolobus solfataricus has been reported as an efficient C-K-producing enzyme, using glycosylated PPD-type ginsenosides as substrates. β-Glycosidase from S. solfataricus can hydrolyze β-d-glucopyranoside in ginsenosides Rc, C-Mc1, and C-Mc, but not α-l-arabinofuranoside in these ginsenosides. To determine candidate residues involved in α-l-arabinofuranosidase activity, compound Mc (C-Mc) was docking to β-glycosidase from S. solfataricus in homology model and sequence was aligned with β-glycosidase from Pyrococcus furiosus that has α-l-arabinofuranosidase activity. A L213A variant β-glycosidase with increased α-l-arabinofuranosidase activity was selected by substitution of other amino acids for candidate residues. The increased α-l-arabinofuranosidase activity of the L213A variant was confirmed through the determination of substrate specificity, change in binding energy, transformation pathway, and C-K production from ginsenosides Rc and C-Mc. The L213A variant β-glycosidase catalyzed the conversion of Rc to Rd by hydrolyzing α-l-arabinofuranoside linked to Rc, whereas the wild-type β-glycosidase did not. The variant enzyme converted ginsenosides Rc and C-Mc into C-K with molar conversions of 97%, which were 1.5- and 2-fold higher, respectively, than those of the wild-type enzyme. Therefore, protein engineering is a useful tool for enhancing the hydrolytic activity on specific glycoside linked to ginsenosides.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29324789      PMCID: PMC5764348          DOI: 10.1371/journal.pone.0191018

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Ginseng (Panax ginseng C. A. Meyer) belongs to the Panax genus of the Araliaceae family and has been used as a traditional medicine in Korea, China, and Japan for thousands of years [1]. Ginsenosides are the main active constituent found in ginseng and possess anti-cancer, anti-fatigue, anti-inflammatory, anti-oxidative, anti-viral, morphine-dependence attenuating, neuroprotective, and vasorelaxative properties [2-7]. Ginsenosides are divided into the protopanaxadiol (PPD) and protopanaxatriol (PPT) types, comprising of sugars linked to the dammarane (tetracyclic triterpene) skeleton. PPD-type ginsenosides contain no sugar, one, or two β-d-glucopyranoses linked to C-3; and no sugar, inner β-d-glucopyranose, or outer α-l-arabinopyranose, α-l-arabinofuranose, or β-d-xylopyranose linked to C-20 [8]. PPT-type ginsenosides contain no sugar, inner β-d-glucopyranose, or outer β-d-glucopyranose, β-d-xylopyranose, or β-d-rhamnopyranose linked to C-6; and no sugar or β-d-glucopyranose linked to C-20. Ginsenosides (Rb1, Rb2, Rc, Rd, Rg1, and Re) in wild ginseng was glycosylated forms contains more than 80%, however, deglycosylated forms in ginseng are present at low concentrations or do not exist. Deglycosylated forms shows greater biological and pharmaceutical activities than glycosylated forms owing to the higher bioavailability and better absorption in the gastrointestinal tract [9]. Compound K (C-K, 20-O-β-d-glucopyranosyl-20(S)-protopanaxadiol) is one molecule of β-d-glucopyranose linked to C-20 in the dammarane skeleton and can be produced from the hydrolysis of glycosylated PPD-type ginsenosides such as Rb1, Rb2, and Rc. C-K has demonstrated beneficial pharmaceutical properties such as anti-allergic, anti-arthritic, anti-carcinogenic, anti-diabetic and anti-inflammatory activities [6, 10–16]. C-K has also exhibited beneficial cosmetic properties such as the alleviation of skin wrinkles and xerosis [17]; and the prevention of UV-induced skin photo-aging and burn-wound healing [18-20]. Therefore, C-K has been used as an essential ingredient in cosmetics and traditional medicine. Diverse methods, such as heating, acid hydrolysis, alkali treatment, and microbial and enzymatic transformation, for obtaining C-K have been carried out due to the absence of C-K in ginseng [21]. Chemical production methods such as acid and alkali treatments induce environmental pollution, while heating method result in low selectivity and yield. In contrast, enzymatic or microbial transformation of C-K from glycosylated PPD-type ginsenosides in ginseng produces no environmental pollution with highly selective hydrolysis. β-Glycosidase from Sulfolobus solfataricus has been an efficient C-K-producing enzyme using glycosylated PPD-type ginsenosides as substrates because of its broad hydrolysis activity, including β-d-glucopyranosidase, β-d-galactopyranosidase, β-d-xylopyranosidase, and α-l-arabinopyranosidase activity [22]. However, this enzyme showed a critical problem that the hydrolysis on PPD-type ginsenosides with α-l-arabinofuranoside was low or absent, and most of these ginsenosides were not hydrolyzed into C-K and accumulated. Among the PPD-type ginsnosides, Rc, compound Mc1 (C-Mc1) and compound Mc (C-Mc) contain α-l-arabinofuranoside in the dammarane skeleton. When the outer β-d-glucopyranoside at C-3 position in Rc is hydrolyzed, it is converted to C-Mc1, which is converted to C-Mc by cleaving the inner β-d-glucopyranoside in C-Mc1. β-Glycosidase from S. solfataricus does not hydrolyze α-l-arabinofuranoside linked to Rc, but slightly hydrolyzed α-l-arabinofuranoside linked to C-Mc because of its low α-l-arabinofuranosidase activity. As a result, most of it is accumulated. However, α-l-arabinofuranosidases from diverse microorganisms show no activity for other glycosides, and it is not suitable for C-K production [8]. Therefore, effective production of C-K from PPD-type ginsenosides requires a variant β-glucosidase with high hydrolysis activity for α-l-arabinofuranoside linked to ginsenosides. In this study, C-Mc docking in homology model, sequence alignment with β-glycosidase from Pyrococcus furiosus containing α-l-arabinofuranosidase activity, and site-directed mutagenesis, time-course reactions were performed. As a result, a L213A variant with increased α-l-arabinofuranosidase activity was obtained. The activity of the L213A variant enzyme for α-l-arabinofuranoside linked to ginsenosides Rc, C-Mc1, and C-Mc was determined and compared to that of the wild-type enzyme. The conversion of ginsenoside Rc to C-K was significantly improved by using the L213A variant enzyme with increased α-l-arabinofuranosidase activity.

Materials and methods

Materials

Ginsenoside standards purchased from Ambo Institute (Seoul, Korea) and BTGin (Daejeon, Korea) were Rb1, Rc, F2, compound O (C-O), compound Y (C-Y), C-Mc, C-Mc1, C-K, Rb2, and Rd. Digoxin was purchased from Sigma (St. Louis. MO, USA) and was added to ginsenoside reaction solution as an internal standard for exact determination of ginsenosides in high-performance liquid chromatography (HPLC).

Gene cloning and site-directed mutagenesis

β-Glycosidase gene of S. solfataricus DSM 1617 (DSMZ, Braunschweig, Germany) was cloned as previously described [23]. Site-directed mutagenesis was performed using a Muta-Direct Site Directed Mutagenesis kit (Intron, Seougnam, Korea), and it were made by polymerase chain reaction (PCR) using synthetic oligonucleotide primers. Primers used to replace the amino acid Leu213 with Ala213 are listed below: forward (5'-CATTCCACATTTAGTCTAGCTATTTTTGCTCCCATTTTTTGTGCATTATC GTGAAA-3'); reverse (5'-TTTCACGATAATGCACAAAAAATGGGAGCAAAAATAGCTAGACTAAA TGTGGAATG-3'). The sequence of mutated PCR product was confirmed by comparing with the DNA sequence of the β-glycosidase of S. solfataricus in the pET-24 vector. The PCR product was treated with Mutazyme enzyme for the digestion of the original DNA template. After enzyme treatment, the mutant gene was transformed into competent cells of Escherichia coli.

Enzyme expression

E. coli expressing β-glycosidase from S. solfataricus was cultivated at 37°C with shaking at 200 rpm in a 2-L Erlenmeyer flask containing 450 mL of Luria-Bertani (LB) medium supplemented with 20 μg/mL of kanamycin. In order to induce enzyme expression, 0.1 mM of isopropyl-β-d-thiogalactopyranoside (IPTG) as a final concentration was added at 0.8 optical density at 600 nm of the culture broth. After induction, the culture temperature and agitation were reduced 16°C and 150 rpm, respectively, and cells were further incubated for 16 h.

Enzyme preparation

Recombinant E. coli expressing wild-type or L213A variant enzyme was harvested and resuspended in 50 mM citrate/phosphate buffer at pH 5.5 or pH 4.5, respectively. The obtained cells were lysed using a sonicator (Sonic Dismembrator Model 100; Fisher Scientific, Pittsburgh, PA, USA) on ice for 20 min. Protein was acquired from the supernatant after centrifugation at 13,000×g for 10 min at 4°C, and it was heated at 70°C for 10 min to denature unwanted proteins derived from E. coli and to purify the thermophilic target protein. The suspension of heat-treated protein was centrifuged at 13,000×g for 10 min in order to remove aggregated proteins. The supernatant obtained was filtered using a 0.45 μm-sterile syringe filter, and the filtrate was used as the purified enzyme in subsequent experiments.

Arabinofuranosidase activity

Reactions were conducted at 80°C in 50 mM citrate/phosphate buffer (pH 5.5) containing 0.4 mg/mL ginsenoside Rc or C-Mc, and 0.15 mg/mL wild-type or variant enzyme. α-l-Arabinofuranosidase activities of the wild-type and variant enzymes were determined on the produced concentrations of ginsenoside Rd or C-K.

Substrate specificity

The substrate specificities of the wild-type and L213A variant β-glycosidases from S. solfataricus were determined by measuring the specific activities for ginsenosides Rb1, Rb2, Rd, F2, C-O, C-Y, C-Mc1, and C-Mc. The specific activity of the variant enzyme for ginsenoside Rc was not determined because it converted Rc to not only C-Mc1 but also Rd. The reactions of the wild-type and L213A variant β-glycosidases from S. solfataricus were carried out at 95°C in 50 mM citrate/phosphate buffer at pH 5.5 and pH 4.5, respectively, and 4% (v/v) dimethyl sulfoxide (DMSO) by varying the enzyme concentration from 0.01 to 0.5 mg/mL and the time from 5 to 30 min. The specific activity was defined as the decreased amount of the substrate ginsenoside (nmol) per min per mg of protein.

Ligand docking

β-Glycosidase from S. solfataricus was modeled using the Build Homology Models module in Discovery Studio 4.0 (Accerlys, San Diego, CA, USA) based on the determined structure of β-glycosidase from S. solfataricus (Protein Data Bank [PDB] entry, 2CEQ) as a template. The substrate C-Mc was docked into the active-site pocket in the models of S. solfataricus β-glycosidase using C-DOCKER, because C-Mc has a similar structure to Rc at C-20 position. The active site defined as a sphere of radius 10 Å around the substrate-binding pocket. The receptor-ligand (enzyme-substrate) docking models giving the lowest interaction energy were chosen for subsequent rounds of docking. Changes in the binding energy between receptor and ligand (∆EBinding) were defined as EComplex − ELigand − EReceptor.

Production of C-K from ginsenoside Rc

The reactions of the wild-type and L213A variant β-glycosidases from S. solfataricus for C-K production using ginsenoside Rc as a substrate were performed in 50 mM citrate/phosphate buffer at pH 5.5 and pH 4.5, respectively, containing 4 mM ginsenoside Rc and 12 mg/mL enzyme. The temperature in these reactions was reduced to 85°C because of the thermostability of this enzyme. The half-life at this temperature was 30 h, indicating that the enzyme is stable during the reactions. The reaction mixtures were sampled, and ginsenoside concentrations were determined using HPLC.

Analytical methods

Digoxin as an internal standard and n-butanol with an equal volume were added to the reaction solution. The solvent in the mixed solution was evaporated, and methanol was added to the evaporated sample. The concentrations of ginsenosides were determined using an HPLC system (Agilent 1100, Agilent, Santa Clara, CA, USA) at a wavelength of 203 nm with a C18 column (YMC, Kyoto, Japan). The column was eluted at 37°C with a linear gradient of acetonitrile/water ranging from 30:70 to 90:10 (v/v) for 95 min at a flow rate of 1 mL/min. Ginsenoside type was identified using the same retention time as that for the ginsenoside standards.

Results and discussion

Selection of a C-K-producing enzyme from ginsenoside Rc

The enzymatic hydrolysis of ginsenoside Rc to PPD-type minor ginsenosides by various microbial enzymes, including α-l-arabinofuranosidases, β-glucosidases, and β-glycosidases is present in Table 1. α-l-Arabinofuranosidases from various microorganisms convert Rc to Rd by hydrolyzing only α-l-arabinofuranoside, while the Rd is not further hydrolyzed by these enzymes. β-Glucosidases and β-glycosidases from various microorganisms transform ginsenoside Rc to C-Mc1, C-Mc, aglycone protopanaxadiol (APPD), and C-K. Among these enzymes, only two enzymes could convert ginsenoside Rc to C-K. β-Glycosidase from P. furiosus produced C-K as an intermediate, which was completely hydrolyzed to APPD [24], and β-glycosidase from S. solfataricus produced C-K as an end product, which hydrolyzes two glucose in C-3, but does not hydrolyze arabinose in C-20 at Rc. Thus, β-glycosidase from P. furiosus and S. solfataricus were selected as a comparison target enzyme and a source enzyme for the increased biotransformation of ginsenoside Rc to C-K, respectively.
Table 1

Enzymatic hydrolysis of ginsenoside Rc to PPD-type ginsenosides.

MicroorganismEnzymeIntermediate productProductReference
Thermotoga thermarumα-l-ArabinofuranosidaseNRRd[30]
Leuconostoc sp.α-l-ArabinofuranosidaseNRRd[31]
Caldicellulosiruptor saccharolyticusα-l-ArabinofuranosidaseNRRd[32]
Rhodanobacter ginsenosidimutansα-l-ArabinofuranosidaseNRRd[28]
Bifidobacterium longumα-l-ArabinofuranosidaseNRRd[33]
Bifidobacterium breveα-l-ArabinofuranosidaseNRRd[34]
Panax ginsengα-l-ArabinofuranosidaseNRRd[35]
Thermus caldophilusβ-GlycosidaseNRRd[36]
Sphingopyxis alaskensisβ-GlucosidaseNRC-Mc1[37]
Arthrobacter chlorophenolicusβ-GlucosidaseNRC-Mc1[38]
Sphingomonas sp. 2F2β-GlucosidaseNRC-Mc1[39]
Penicillium aculeatumβ-GlucosidaseC-Mc1C-Mc[40]
Dictyoglomus turgidumβ-GlucosidaseNDC-Mc[41]
Sulfolobus acidocaldariusβ-GlycosidaseNDC-Mc[42]
Pyrococcus furiosusβ-GlycosidaseRd, C-KAPPD[24]
Sulfolobus solfataricusβ-GlycosidaseC-McC-K[29]

NR, not reported; ND, not detected

NR, not reported; ND, not detected β-Glycosidase from S. solfataricus is an effective C-K producer because the enzyme can hydrolyze β-d-glucopyranose linked to C-3, outer β-d-glucopyranose, α-l-arabinopyranose, α-l-arabinofuranose, and β-d-xylopyranose linked to C-20 of the dammarane skeleton in PPD-type ginsenosides but does not hydrolyze inner β-d-glucopyranose linked to C-20 [25-28]. β-Glycosidase from S. solfataricus can hydrolyze β-d-glucopyranoside linked to ginsenosides such as Rc, C-Mc1, and C-Mc, which are converted into C-Mc1, C-Mc, and C-K, respectively. However, this enzyme showed low or no hydrolytic activity on α-l-arabinofuranoside linked to Rc, C-Mc1, and C-Mc. For the efficient biotransformation of ginsenoside Rc to C-K, a β-glycosidase variant with increased α-l-arabinofuranosidase activity should be achieved.

Achievement of a variant β-glycosidase from S. solfataricus with increased α-l-arabinofuranosidase activity

In order to identify the residue involved in α-l-arabinofuranoside hydrolysis, a C-Mc docked model was constructed based on the reported crystal structure of β-glycosidase from S. solfataricus. Rc could not docked to the wild-type β-glycosidase because it has a large molecular size. The outer α-l-arabinofuranoside at C-20 of C-Mc is the same as that of the smaller molecular size Rc. Therefore, we used C-Mc in docking to β-glycosidase from S. solfataricus, instead of Rc. In the ligand docked model, four non-catalytic and two catalytic residues within a 4 Å of the substrate were identified. The non-catalytic residues were Leu213, Glu217, Lys219, and His342 and the catalytic residues were Glu206 and Glu387 (Fig 1A). Since β-glycosidase from P. furiosus showed high hydrolytic activity on α-l-arabinofuranoside linked to ginsenosides Rc and C-Mc [24], the sequence of β-glycosidase from S. solfataricus was aligned with that of β-glycosidase from P. furiosus that has α-l-arabinofuranosidase activity to determine candidate residues involved in α-l-arabinofuranosidase activity in β-glycosidase from S. solfataricus (Fig 1B). Glu206, and Glu387 were all conserved in the two enzymes. Therefore, Leu213, Glu217, Lys219, and His342 were selected as candidate residues.
Fig 1

Construction of ligand docked pose and sequence alignment on S. solfataricus β-glycosidase.

(A) Docking of C-Mc to S. solfataricus β-glycosidase in the homology model. The C-Mc ligand was docked to the active site of β-glycosidase from S. solfataricus (2CEQ), and amino acid residues within 4 Å distance of the substrate in the ligand docked model were selected. The selected non-catalytic residues, catalytic residues, and C-Mc are colored with red, blue, and green, respectively. (B) Amino acid sequence alignment of S. solfataricus β-glycosidase with P. furiosus β-glycosidase. The catalytic residues (Glu206 and Glu387) and non-catalytic residues (Leu213, Glu217, Lys219, and His342) of S. solfataricus β-glycosidase are colored with red and blue boxes, respectively.

Construction of ligand docked pose and sequence alignment on S. solfataricus β-glycosidase.

(A) Docking of C-Mc to S. solfataricus β-glycosidase in the homology model. The C-Mc ligand was docked to the active site of β-glycosidase from S. solfataricus (2CEQ), and amino acid residues within 4 Å distance of the substrate in the ligand docked model were selected. The selected non-catalytic residues, catalytic residues, and C-Mc are colored with red, blue, and green, respectively. (B) Amino acid sequence alignment of S. solfataricus β-glycosidase with P. furiosus β-glycosidase. The catalytic residues (Glu206 and Glu387) and non-catalytic residues (Leu213, Glu217, Lys219, and His342) of S. solfataricus β-glycosidase are colored with red and blue boxes, respectively. The candidate residues were mutated as shown in Table 2. The wild-type and Lys219, and His342 variant enzymes showed no hydrolytic activity on α-l-arabinofuranoside linked to Rc, while the Glu217 variant enzyme exhibited no hydrolytic activity on α-l-arabinofuranoside linked to C-Mc. However, the L213A, L213Q, and L213W variant enzymes hydrolyzed α-l-arabinofuranoside linked to both Rc and C-Mc, while the L213A variant enzyme showed higher α-l-arabinofuranosidase activity than those of the L213Q and L213W variant enzymes. Thus, we used the L213A variant enzyme for hydrolysis of α-l-arabinofuranoside linked to Rc and C-Mc. α-l-Arabinofuranosidase hydrolyzes α-l-arabinofuranoside linked to Rc to form Rd, but not β-d-glucopyranosides linked to Rd and the wild-type β-glycosidase from S. solfataricus cannot hydrolyzes α-l-arabinofuranoside linked to Rc, indicating that the enzymes do not convert Rd and Rc into C-K, respectively. In contrast, the L213A variant can convert Rd and Rc into C-K.
Table 2

Produced concentrations of ginsenoside Rd and C-K from ginsenoside Rc and C-Mc, respectively, by the wild-type and variant β-glycosidases of S. solfataricus.

Numerical values in round brackets present the experimental data under optimum conditions (95°C, pH 4.5, and 4% DMSO).

EnzymeProduct (μM)
RdC-K
Wild-type0198 ± 3.0
L213A63.4 ± 1.1 (75.7±0.8)386 ± 2.0 (437 ± 3.0)
L213Q19.7 ± 0.4343 ± 4.0
L213R00
L213W11.9 ± 0.2209 ± 4.0
L213S10.3 ± 0.10
L213G26.1 ± 0.50
L213D2.7 ± 0.10
L213E1.4± 0.10
L213H1.8 ± 0.10
G217A4.8 ± 0.10
G217N23.4 ± 0.40
K219R0259 ± 2.0
H342A0243.0 ± 3.0
H342E00

ND, not detected

Produced concentrations of ginsenoside Rd and C-K from ginsenoside Rc and C-Mc, respectively, by the wild-type and variant β-glycosidases of S. solfataricus.

Numerical values in round brackets present the experimental data under optimum conditions (95°C, pH 4.5, and 4% DMSO). ND, not detected

Substrate specificities of the wild-type and L213A variant β-glycosidases from S. solfataricus for PPD-type ginsenosides

The substrate specificities of the wild-type and L213A variant β-glycosidases from S. solfataricus were determined using the PPD-type ginsenosides C-Mc, C-Mc1, Rd, Rb1, Rb2, F2, C-O, and C-Y (Table 3). The specific hydrolytic activities for the wild-type and L213A variant enzymes followed the order F2 > Rb1 > C-O > C-Y > Rb2 > Rd > C-Mc> C-Mc1 and F2 > Rb1 > C-O > C-Y > Rb2 > C-Mc > Rd > C-Mc1, respectively. The wild-type enzyme exhibited no α-l-arabinofuranosidase activity for ginsenoside Rc, but the L213A variant enzyme showed. The activity of the L213A variant enzyme for C-Mc was 2.2-fold higher than that of the wild-type enzyme, respectively, whereas that for C-Y was 1.5-fold lower, indicating increased α-l-arabinofuranosidase activity and decreased α-l-arabinopyranosidase activity, respectively. To explain the increased α-l-arabinofuranosidase activity of the L213A variant, we calculated the changes in binding energy (∆Ebinding) of the ligand-binding enzymes. The changes in the binding energy of the wild-type and L213A variant β-glycosidases docked with C-Mc were −86.5 and −177.2 kcal mol−1, respectively. The 2-fold lower binding energy of the variant β-glycosidase suggests that it has a higher regioselectivity and forms a more stable complex.
Table 3

Substrate specificity of the wild-type and L213A variant β- glycosidase from S. solfataricus for the PPD-type ginsenosides.

SubstrateProductSpecific activity (nmol/min/mg)
Wild-typeL213A
C-McC-K66.1 ± 0.9146 ± 0.5
C-Mc1C-K12.6 ± 1.356.7 ± 0.9
RdC-K211 ± 2.980.2 ± 1.8
Rb1C-K8560 ± 12013650 ± 290
Rb2C-K520 ± 10540 ± 10
F2C-K24100 ± 15033400 ± 210
C-OC-K4240 ± 1104050 ± 20
C-YC-K1740 ± 101180 ± 10

Transformation pathways of the wild-type and L213A variant β-glycosidases from S. solfataricus

The transformation pathway of ginsenoside Rb1, Rb2, Rc, or Rd to C-K by the wild-type β-glycosidase from S. solfataricus was previously reported as Rb1 or Rb2 → Rd → F2 → C-K, and RcC-Mc1C-McC-K [29]. Ginsenoside Rc was not converted to Rd due to an absence of α-l-arabinofuranosidase activity of the wild-type enzyme for ginsenoside Rc. The L213A variant enzyme included the pathway of Rc → Rd → F2 → C-K in addition to the previous one due to its α-l-arabinofuranosidase activity for ginsenoside Rc (Fig 2). The wild-type and L213A variant enzymes converted C-O and C-Y into C-K (Table 3). The enzymes converted Rb2 into not only Rd as a major product but also C-O as a minor product. Thus, we established another C-K-producing transformation pathway: Rb2C-O → C-YC-K in the wild-type and L213A variant enzymes.
Fig 2

Biotransformation pathways from ginsenosides Rb1, Rb2, and Rc to C-K by the wild-type and L213A variant β-glycosidases from S. solfataricus.

The black arrow indicates newly formed hydrolytic activity by the L213A variant.

Biotransformation pathways from ginsenosides Rb1, Rb2, and Rc to C-K by the wild-type and L213A variant β-glycosidases from S. solfataricus.

The black arrow indicates newly formed hydrolytic activity by the L213A variant.

C-K production from ginsenoside Rc and C-Mc by wild-type and L213A variant β-glycosidases from S. solfataricus

The time-course reactions of Rc to C-K by the wild-type and L213A variant enzymes were quantitatively analyzed by the HPLC system. The wild-type and L213A variant β-glycosidases from S. solfataricus converted 4 mM ginsenoside Rc to 2.5 mM C-K via C-Mc and 3.8 mM C-K via Rd and C-Mc, respectively, in 10 h. The molar conversions of these reactions were 62% and 97%, respectively (Fig 3 and Fig 4). The amount of C-K produced from Rc by the variant enzyme was 1.5-fold higher than that by the wild-type enzyme. The wild-type and variant enzymes converted 4 mM C-Mc to 1.9 mM and 3.8 mM C-K, respectively, in 14 h. The molar conversions were 47% and 97%, respectively (Fig 5 and Fig 6). The amount of C-K produced from Rc by the variant enzyme was 2.0-fold higher than that by the wild-type enzyme.
Fig 3

C-K production from ginsenoside Rc via C-Mc with Rd and C-Mc as intermediates by (A) the wild-type and (B) L213A variant Ginsenoside Rc (filled circle), Rd (open circle), C-Mc (filled triangle), and C-K (filled square).

Fig 4

HPLC profiles of the reaction solutions obtained after 4 h and 10 h for the production of C-K from ginsenoside Rc by (A) the wild-type and (B) L213A variant β-glycosidases from S. solfataricus.

Fig 5

C-K production from ginsenoside Mc by (A) the wild-type and (B) L213A variant Ginsenoside C-Mc (filled triangle), and C-K (filled square).

Fig 6

HPLC profiles of the reaction solutions obtained after 14 h for the production of C-K from ginsenoside Mc by (A) the wild-type and (B) L213A variant enzymes from S. solfataricus.

C-K production from ginsenoside Rc via C-Mc with Rd and C-Mc as intermediates by (A) the wild-type and (B) L213A variant Ginsenoside Rc (filled circle), Rd (open circle), C-Mc (filled triangle), and C-K (filled square). HPLC profiles of the reaction solutions obtained after 4 h and 10 h for the production of C-K from ginsenoside Rc by (A) the wild-type and (B) L213A variant β-glycosidases from S. solfataricus. C-K production from ginsenoside Mc by (A) the wild-type and (B) L213A variant Ginsenoside C-Mc (filled triangle), and C-K (filled square). HPLC profiles of the reaction solutions obtained after 14 h for the production of C-K from ginsenoside Mc by (A) the wild-type and (B) L213A variant enzymes from S. solfataricus.

Conclusions

β-glycosidase from S. solfataricus is the most efficient producer of C-K from PPD-type ginsenosides. However, this enzyme has a critical problem in that low or no hydrolytic activity is seen on α-l-arabinofuranoside linked to ginsenosides. To solve this problem, an L213A variant with increased α-l-arabinofuranosidase activity was obtained through protein engineering based on a ligand docked homology model and sequence alignment. The variant enzyme converted ginsenoside Rc and C-Mc to C-K with both molar conversions of 97%, which was 35% and 50% higher than the wild-type enzyme, respectively. Therefore, protein engineering is a useful tool for enhancing the hydrolytic activity of specific glycosides linked to ginsenosides.
  39 in total

1.  Microbial conversion of major ginsenoside rb(1) to pharmaceutically active minor ginsenoside rd.

Authors:  Myung Kyum Kim; Jun Won Lee; Ki Young Lee; Deok-Chun Yang
Journal:  J Microbiol       Date:  2005-10       Impact factor: 3.422

2.  Characterization of a novel arabinose-tolerant α-L-arabinofuranosidase with high ginsenoside Rc to ginsenoside Rd bioconversion productivity.

Authors:  J Xie; D Zhao; L Zhao; J Pei; W Xiao; G Ding; Z Wang; J Xu
Journal:  J Appl Microbiol       Date:  2016-02-09       Impact factor: 3.772

Review 3.  Biotransformation of ginsenosides by hydrolyzing the sugar moieties of ginsenosides using microbial glycosidases.

Authors:  Chang-Su Park; Mi-Hyun Yoo; Kyeong-Hwan Noh; Deok-Kun Oh
Journal:  Appl Microbiol Biotechnol       Date:  2010-04-08       Impact factor: 4.813

4.  Enzymatic transformation of the major ginsenoside Rb2 to minor compound Y and compound K by a ginsenoside-hydrolyzing β-glycosidase from Microbacterium esteraromaticum.

Authors:  Lin-Hu Quan; Yan Jin; Chao Wang; Jin-Woo Min; Yeon-Ju Kim; Deok-Chun Yang
Journal:  J Ind Microbiol Biotechnol       Date:  2012-06-21       Impact factor: 3.346

5.  Ginsenoside Rd production from the major ginsenoside Rb(1) by beta-glucosidase from Thermus caldophilus.

Authors:  Ju-Wan Son; Hye-Jung Kim; Deok-Kun Oh
Journal:  Biotechnol Lett       Date:  2007-11-08       Impact factor: 2.461

6.  Exo-glucosidase activity and substrate specificity of the beta-glycosidase isolated from the extreme thermophile Sulfolobus solfataricus.

Authors:  R Nucci; M Moracci; C Vaccaro; N Vespa; M Rossi
Journal:  Biotechnol Appl Biochem       Date:  1993-04       Impact factor: 2.431

Review 7.  Ginseng compounds: an update on their molecular mechanisms and medical applications.

Authors:  Jian-Ming Lü; Qizhi Yao; Changyi Chen
Journal:  Curr Vasc Pharmacol       Date:  2009-07       Impact factor: 2.719

8.  Production of ginsenoside Rd from ginsenoside Rc by α-L-arabinofuranosidase from Caldicellulosiruptor saccharolyticus.

Authors:  Kyung-Chul Shin; Gi-Woong Lee; Deok-Kun Oh
Journal:  J Microbiol Biotechnol       Date:  2013-04       Impact factor: 2.351

9.  20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol suppresses UV-Induced MMP-1 expression through AMPK-mediated mTOR inhibition as a downstream of the PKA-LKB1 pathway.

Authors:  Dong Joo Shin; Jong-Eun Kim; Tae-Gyu Lim; Eun Hee Jeong; Gaeun Park; Nam Joo Kang; Jun-Seong Park; Myeong-Hun Yeom; Deok Kun Oh; Ann M Bode; Zigang Dong; Hyong Joo Lee; Ki Won Lee
Journal:  J Cell Biochem       Date:  2014-10       Impact factor: 4.429

10.  Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells.

Authors:  Yan Chen; Yajing Xu; Yan Zhu; Xiaolin Li
Journal:  Cancer Cell Int       Date:  2013-03-12       Impact factor: 5.722

View more
  4 in total

Review 1.  Biocatalytic strategies for the production of ginsenosides using glycosidase: current state and perspectives.

Authors:  Wei-Na Li; Dai-Di Fan
Journal:  Appl Microbiol Biotechnol       Date:  2020-03-03       Impact factor: 4.813

Review 2.  Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation.

Authors:  Zhaoqiang Chen; Zepeng Zhang; Jiaqi Liu; Hongyu Qi; Jing Li; Jinjin Chen; Qingxia Huang; Qing Liu; Jia Mi; Xiangyan Li
Journal:  Front Cell Infect Microbiol       Date:  2022-04-25       Impact factor: 6.073

Review 3.  A narrative review of the pharmacology of ginsenoside compound K.

Authors:  Tao Liu; Lu Zhu; Li Wang
Journal:  Ann Transl Med       Date:  2022-02

Review 4.  Production of Minor Ginsenoside CK from Major Ginsenosides by Biotransformation and Its Advances in Targeted Delivery to Tumor Tissues Using Nanoformulations.

Authors:  Mohanapriya Murugesan; Ramya Mathiyalagan; Vinothini Boopathi; Byoung Man Kong; Sung-Keun Choi; Chang-Soon Lee; Deok Chun Yang; Se Chan Kang; Thavasyappan Thambi
Journal:  Nanomaterials (Basel)       Date:  2022-09-30       Impact factor: 5.719

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.